Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1201-3. doi: 10.1136/jnnp.2005.084673. Epub 2006 Mar 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Amyloid beta-Peptides / metabolism
  • Cohort Studies
  • Diagnosis, Differential
  • Female
  • Humans
  • Huntington Disease / diagnosis*
  • Huntington Disease / pathology*
  • Male
  • Middle Aged
  • Peptide Fragments / cerebrospinal fluid
  • Peptide Fragments / metabolism

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (10-43)